Ketoconazole enantiomer for the treatment of diabetes mellitus (Q34090860)

30 July 2017

1 reference

title

Ketoconazole enantiomer for the treatment of diabetes mellitus (English)

1 reference

30 July 2017

1 reference

Richard Arakaki

1

1 reference

PubMed ID

20047506

30 July 2017

Bernice Welles

series ordinal

2

1 reference

PubMed ID

20047506

30 July 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

1 reference

30 July 2017

19

1 reference

30 July 2017

185-194

1 reference

30 July 2017

2

1 reference

10-year follow-up of intensive glucose control in type 2 diabetes

30 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

UKPDS and the legacy effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Modulation of glucocorticoid action and the treatment of type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Ketoconazole treatment in Cushing's syndrome: experience in 34 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Determination of the absolute configuration and solution conformation of the antifungal agents ketoconazole, itraconazole, and miconazole with vibrational circular dichroism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Stereoisomers of ketoconazole: preparation and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903381411

10.1517/13543780903381411

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

20047506